Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Zhong Mei Zhou"'
Publikováno v:
Oncology Letters. 10:1287-1292
The mechanisms underlying drug resistance in colorectal cancer (CRC) treatment remain to be fully elucidated. Therefore, the present study aimed to investigate the underlying mechanism resistance to a widely used anticancer drug, 5-Fluorouracil (5-FU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4977c53a83c1c2651c31e96c5643f
https://doi.org/10.3892/ol.2015.3468
https://doi.org/10.3892/ol.2015.3468
Publikováno v:
International journal of pharmaceutics. 513(1-2)
In this study, we have demonstrated gemcitabine (GEM)-conjugated amphiphilic biodegradable polymeric drug carriers. Our aim was to increase the chemotherapeutic potential of GEM in colon cancer by forming a unique polymer-drug conjugates. The polymer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf72d92aac18593a2499c22598785f6
https://pubmed.ncbi.nlm.nih.gov/27613255
https://pubmed.ncbi.nlm.nih.gov/27613255
Autor:
Tong Yu Lin, Dong Geng Liu, Zhong Zhen Guan, Yu Hong Li, Zhong Mei Zhou, Hui Qiang Huang, You Jian He, Li Zhang, Rui Hua Xu, Wen Qi Jiang, Xiao Fei Sun
Publikováno v:
Chinese Journal of Cancer Research. 14:50-53
Objective: High dose chemotherapy supported by autologous hematopoietic stem cells transplantation (AHSCT) has developed dramaticly in recent years and become the most effective approach to improve radical treatment for the chemo-sensitive lymphoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d7931d6229d98da41165f9758323975
https://doi.org/10.1007/s11670-002-0011-x
https://doi.org/10.1007/s11670-002-0011-x
Publikováno v:
Journal of Computer Applications. 30:3374-3376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90d8d8f5f2aa151ff39c12b9e0c19288
https://doi.org/10.3724/sp.j.1087.2010.03374
https://doi.org/10.3724/sp.j.1087.2010.03374
Publikováno v:
Journal of Computer Applications. 29:3287-3289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6105d022217e12269ee99fe03b4ab96f
https://doi.org/10.3724/sp.j.1087.2009.03287
https://doi.org/10.3724/sp.j.1087.2009.03287
Publikováno v:
Chinese Journal of Cancer Research. 11:200-203
Objective: A pilot study to test the feasibility and efficacy of hig h dose IFO and standard dose ADR and DTIC with G-CSF support in treatment of advanced soft tissue sarcoma (STS). Methods: 35 patients of no prior chemotherapy with metastatic or loc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cad887b3fee8ea7f0279db068335898c
https://doi.org/10.1007/s11670-999-0012-0
https://doi.org/10.1007/s11670-999-0012-0
Autor:
Zhong-yu, Yuan, Shu-sen, Wang, Mei-qin, Zhu, Lei, Zheng, Wen-biao, Luo, Zhong-mei, Zhou, Zhong-zhen, Guan
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 30(6)
To investigate the clinical characteristics and prognosis of patients with different subtypes of breast cancer: basaloid, HER-2 and luminal types, and try to find the evidence of individualized treatment for the patients.1280 histologically and immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32b056723e07249ca7fa5f81a89dc95f
https://pubmed.ncbi.nlm.nih.gov/19024523
https://pubmed.ncbi.nlm.nih.gov/19024523
Autor:
Xiao-fei, Sun, Zi-jun, Zhen, Dong-geng, Liu, Zhong-jun, Xia, Hui-qiang, Huang, Li, Zhang, Zhong-mei, Zhou, Yu-hong, Li, Yi, Xia, Jia-yu, Ling, Zhong-zhen, Guan
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 29(1)
This study was designed to evaluate the efficacy and toxicity of modified BFM-90 regimen originated from Germany authors in the treatment of Chinese childhood and adolescent lymphoblastic lymphoma.Thirty-six untreated lymphoblastic lymphoma patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27cbd1d3619c14e854aaa370b6c0593a
https://pubmed.ncbi.nlm.nih.gov/17575697
https://pubmed.ncbi.nlm.nih.gov/17575697
Autor:
Xiao-Xiao, Wang, Zhong-Mei, Zhou, Zhong-Yu, Yuan, Dong-Sheng, Zhang, Yan-Xia, Shi, Wen-Qi, Jiang
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 26(4)
Few treatment options are available for metastatic breast cancer with resistance to both anthracycline-and taxane-based chemotherapy regimens. Docetaxel combined capecitabine (DC regimen) is approved as a new active regimen for metastatic breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59f8719537002cd53b3a23c6ab349dc8
https://pubmed.ncbi.nlm.nih.gov/17430662
https://pubmed.ncbi.nlm.nih.gov/17430662
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 25(9)
Anemia is a common complication of cancer patients. Recombinant human erythropoietin (rhEPO) can alleviate the symptoms of cancer-related anemia. However, the optimal use of rhEPO is still on investigation. This study was to find out the optimal use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84ff8a7a9cd8c9281b145b627e6cc0cb
https://pubmed.ncbi.nlm.nih.gov/16965653
https://pubmed.ncbi.nlm.nih.gov/16965653